RxDoctor Payments Data

Michelle Longmire, MD

Dermatology · Stanford, CANPI 1659691723

Payments from drug & device makers

$3,373in general payments, 2019–2025

Across 17 payments — averaging $198.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$3K
  • Novartis$145
  • Regeneron$139
  • Johnson & Johnson$38
  • Lilly USA, LLC$34
  • AbbVie$26
  • plus $40 from 2 others

What the payments were for

  • Consulting fees$2,80083%
  • Travel & lodging$1504%
  • Food & beverage$42313%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck2$2,950
Novartis8$145
Regeneron1$139
Johnson & Johnson2$38
Lilly USA, LLC1$34
AbbVie1$26
UCB, Inc.1$23
Sanofi1$18

How this compares

$3,373 in reported general payments places this provider in the 60th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California

Medicare billing

Part B allowed, 2024
$4,607
Medicare patients
17
Services billed
69

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →